Literature DB >> 24607334

Superficial siderosis associated with aceruloplasminemia. Case report.

Akira Matsushima1, Toshikazu Yoshida2, Kunihiro Yoshida3, Shinji Ohara4, Yasuko Toyoshima5, Akiyoshi Kakita5, Shu-Ichi Ikeda1.   

Abstract

A 63-year-old woman with a past history of right subdural hematoma (SDH) at the age of 61 years was referred to our hospital under a suspicion of aceruloplasminemia (ACP). A neurological examination revealed very mild cognitive impairment and cerebellar ataxia. Blood chemistry data showed deficient ceruloplasmin (Cp), decreased copper, and increased ferritin. A nonsense mutation (c.2630G>A, p.Trp858Ter) was detected in the Cp gene. Brain magnetic resonance imaging (MRI) showed marked hypointensity at the surface of the cerebrum, cerebellum, and brainstem bilaterally, in addition to the bilateral basal ganglia, thalamus, and dentate nucleus, suggesting the coexistence of ACP and superficial siderosis (SS). The characteristics of SS in ACP have not been examined neuroradiologically or neuropathologically in great detail, while SDH and its curative surgery are known to cause SS. The distribution of the hypointensity areas on MRI was expanded bilaterally to the subtentorial areas of this patient, which was much more widespread than observed in typical SS after SDH. We speculate that the underlying ACP may expand the SS induced by SDH. Cp would accelerate iron export from the brain via the blood-cerebrospinal fluid (CSF) barrier, or CSF-brain barrier when excessive iron is loaded into the subarachnoid space.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aceruloplasminemia; Blood–cerebrospinal fluid (CSF) barrier; CSF–brain barrier; Ceruloplasmin; Macrophage; Superficial siderosis

Mesh:

Substances:

Year:  2014        PMID: 24607334     DOI: 10.1016/j.jns.2014.02.014

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

1.  Pancytopenia and Myelodysplastic Changes in Aceruloplasminemia: A Case with a Novel Pathogenic Variant in the Ceruloplasmin Gene.

Authors:  Ayako Yamamura; Yoshitaka Kikukawa; Kenji Tokunaga; Eiko Miyagawa; Shinya Endo; Hirosada Miyake; Hiroyuki Hata; Hiroaki Mitsuya; Kunihiro Yoshida; Masao Matsuoka
Journal:  Intern Med       Date:  2018-02-09       Impact factor: 1.271

Review 2.  Emerging Disease-Modifying Therapies in Neurodegeneration With Brain Iron Accumulation (NBIA) Disorders.

Authors:  Vassilena Iankova; Ivan Karin; Thomas Klopstock; Susanne A Schneider
Journal:  Front Neurol       Date:  2021-04-15       Impact factor: 4.003

3.  Severe Protein-Calorie Malnutrition-Associated Hepatic Steatosis in a Woman Who Had Roux-en-Y Gastric Bypass for Morbid Obesity Thirteen Years Ago.

Authors:  Guriel N Kim; Sam Ho; David Saulino; Xiuli Liu
Journal:  Gastroenterology Res       Date:  2021-04-21

4.  A novel ceruloplasmin mutation identified in a Chinese patient and clinical spectrum of aceruloplasminemia patients.

Authors:  Wan-Qing Xu; Wang Ni; Rou-Min Wang; Yi Dong; Zhi-Ying Wu
Journal:  Metab Brain Dis       Date:  2021-08-04       Impact factor: 3.584

5.  Effects of iron chelation therapy on the clinical course of aceruloplasminemia: an analysis of aggregated case reports.

Authors:  Lena H P Vroegindeweij; Agnita J W Boon; J H Paul Wilson; Janneke G Langendonk
Journal:  Orphanet J Rare Dis       Date:  2020-04-25       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.